ACUTE AND LONG-TERM RESPONSE TO MK-421, A LONG-ACTING ORAL CONVERTING ENZYME-INHIBITOR, IN HEART-FAILURE

被引:0
作者
LEVINE, TB [1 ]
OLIVARI, MT [1 ]
COHN, JN [1 ]
机构
[1] UNIV MINNESOTA,MINNEAPOLIS,MN 55455
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:209 / 209
页数:1
相关论文
共 50 条
  • [21] LISINOPRIL AND CAPTOPRIL IN THE TREATMENT OF HEART-FAILURE IN OLDER PATIENTS - COMPARISON OF A LONG-ACTING AND SHORT-ACTING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    GILES, TD
    FISHER, MB
    RUSH, JE
    AMERICAN JOURNAL OF MEDICINE, 1988, 85 (3B) : 44 - 47
  • [22] HEMODYNAMIC AND CLINICAL-RESPONSE TO ENALAPRIL, A LONG-ACTING CONVERTING-ENZYME INHIBITOR, IN PATIENTS WITH CONGESTIVE HEART-FAILURE
    LEVINE, TB
    OLIVARI, MT
    GARBERG, V
    SHARKEY, SW
    COHN, JN
    CIRCULATION, 1984, 69 (03) : 548 - 553
  • [23] DETERMINANTS OF ACUTE AND LONG-TERM RESPONSE TO CONVERTING ENZYME-INHIBITORS IN CONGESTIVE HEART-FAILURE
    LEVINE, TB
    COHN, JN
    AMERICAN HEART JOURNAL, 1982, 104 (05) : 1159 - 1164
  • [24] THE ORAL CONVERTING ENZYME-INHIBITOR CAPTOPRIL IN HEART-FAILURE - ACUTE HEMODYNAMIC-EFFECTS, LONG-TERM TREATMENT, COMPARISON WITH PRAZOSIN (RALPH-READER PRIZE)
    SHARPE, DN
    COXON, R
    LONG, B
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1981, 11 (04): : 452 - 452
  • [25] EFFECT OF THE ANGIOTENSIN-I CONVERTING ENZYME-INHIBITOR, MK-421, ON EXPERIMENTALLY INDUCED DRINKING
    FREGLY, MJ
    FATER, DC
    GREENLEAF, JE
    APPETITE, 1982, 3 (04) : 309 - 319
  • [26] EFFECTS OF A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, MK-421, IN NORMAL MEN AND PATIENTS
    KONO, T
    OSEKO, F
    IKEDA, F
    NAKANO, R
    TANIGUCHI, A
    IMURA, H
    ENDO, J
    ENDOCRINOLOGIA JAPONICA, 1982, 29 (05): : 615 - 622
  • [27] ANGIOTENSIN CONVERTING ENZYME-INHIBITION BY MK421 - A POTENT LONG-ACTING ORAL-AGENT
    JACKSON, B
    JOHNSTON, CI
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1982, 12 (04): : 362 - 362
  • [28] A MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF BENAZEPRIL HYDROCHLORIDE, A LONG-ACTING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE
    INSEL, J
    MIRVIS, DM
    BOLAND, MJ
    CINQUEGRANI, MP
    SHANES, J
    RUBIN, SA
    WHALEN, JJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (03) : 312 - 320
  • [29] HEMODYNAMIC-RESPONSE TO CAPTOPRIL, AN ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN CONGESTIVE HEART-FAILURE
    LEVINE, TB
    COHN, JN
    CARLYLE, PF
    GROSS, KA
    CLINICAL RESEARCH, 1979, 27 (02): : A439 - A439
  • [30] ACUTE AND LONG-TERM EFFECTS OF THE NEW CONVERTING ENZYME-INHIBITOR MK 421 ON BLOOD-PRESSURE AND THE RENIN-ANGIOTENSIN SYSTEM IN HYPERTENSIVE PATIENTS
    KOLLOCH, R
    STUMPE, KO
    BAHNER, U
    KRUCK, F
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1982, 12 (02) : 20 - 20